1H0C
The crystal structure of human alanine:glyoxylate aminotransferase
1H0C の概要
エントリーDOI | 10.2210/pdb1h0c/pdb |
分子名称 | SERINE--GLYOXYLATE AMINOTRANSFERASE, PYRIDOXAL-5'-PHOSPHATE, (AMINOOXY)ACETIC ACID, ... (5 entities in total) |
機能のキーワード | aminotransferase, pyridoxal phosphate, transferase |
由来する生物種 | HOMO SAPIENS (HUMAN) |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 43953.61 |
構造登録者 | |
主引用文献 | Zhang, X.,Roe, S.M.,Roe, S.M.,Hou, Y.,Bartlam, M.,Rao, Z.,Pearl, L.H.,Danpure, C.J. Crystal Structure of Alanine:Glyoxylate Aminotransferase and the Relationship between Genotype and Enzymatic Phenotype in Primary Hyperoxaluria Type 1. J.Mol.Biol., 331:643-, 2003 Cited by PubMed Abstract: A deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase (AGT) is responsible for the potentially lethal hereditary kidney stone disease primary hyperoxaluria type 1 (PH1). Many of the mutations in the gene encoding AGT are associated with specific enzymatic phenotypes such as accelerated proteolysis (Ser205Pro), intra-peroxisomal aggregation (Gly41Arg), inhibition of pyridoxal phosphate binding and loss of catalytic activity (Gly82Glu), and peroxisome-to-mitochondrion mistargeting (Gly170Arg). Several mutations, including that responsible for AGT mistargeting, co-segregate and interact synergistically with a Pro11Leu polymorphism found at high frequency in the normal population. In order to gain further insights into the mechanistic link between genotype and enzymatic phenotype in PH1, we have determined the crystal structure of normal human AGT complexed to the competitive inhibitor amino-oxyacetic acid to 2.5A. Analysis of this structure allows the effects of these mutations and polymorphism to be rationalised in terms of AGT tertiary and quaternary conformation, and in particular it provides a possible explanation for the Pro11Leu-Gly170Arg synergism that leads to AGT mistargeting. PubMed: 12899834DOI: 10.1016/S0022-2836(03)00791-5 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.5 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
